Objective and design: This study systematically examined salivary composition and taste perception and monitored related subjective complaints in a group of bulimia nervosa (BN) patients. Subjects: Fifty-two consenting female individuals participated in the current cross-sectional study, 26 patients diagnosed with BN according to the Diagnostic and statistical manual of mental disorders-IV (DSM-IV) criteria (mean age: 2477 years) and 26 healthy controls matching in age and body mass index (BMI). Methods: All participants were given diagnostic BN-related questionnaires, had taste and salivary-composition analyses and were monitored for oral sensorial complaints. The patients were also subjected to psychological and psychiatric examinations focusing on established criteria known to be pathognomonic of the disease (including binge eating episodes, depression, impulsive traits, enhanced awareness of body image, typical compensatory behavior, and so on). Results: The self-answered questionnaires of bulimic investigatory test Edinburgh (BITE), Beck Depression Inventory (BDI), brief symptom inventory (BSI) and impulsivity scale (IS) revealed highly significant differences between the two groups with respect to the various BN diagnostic symptoms of the patients (P ¼ 0.0001). Subjective and objective examinations showed an overall disturbed salivary and taste profile in BN patients, who complained of xerostomia (dry mouth) and taste aberration or oral burning sensation. Conclusions: Regardless of the specific mechanism responsible for the disturbed salivary and taste profile in BN patients, these observed changes are associated with active illness. Accordingly, administration of therapeutic agents, including antioxidants, anti-inflammatory drugs and saliva substitutes, to the oral cavity (and maybe even systemically) of BN patients should be considered.
Introduction
Bulimia nervosa (BN) is an eating disorder characterized by repeated episodes of binge eating episodes followed by compensatory behavior of self-induced vomiting (known as 'purging'), abuse of laxatives and/or diuretics, strict dieting, rigorous fasting or vigorous physical exercise for the purpose of strict weight control (American Psychiatric Association, 1994) . The syndrome predominantly affects young women. Oral, gastrointestinal, and serious electrolyte and endocrine complications are common among BN patients, and it is widely recognized that the oral cavity and salivary glands are involved (Tylenda et al., 1991; Milosevic and Dawson, 1996) . Parotid gland enlargement occurs in about 8% of patients with the 'purging' syndrome common in BN (Riad et al., 1991) , whereas bulimics manifest a significantly higher retention of dental plaque, higher frequency of dental erosion and more extensive caries (Milosevic and Dawson, 1996; Scheutzel, 1996; Rytomaa et al., 1998) . However, the increased occurrence of dental erosion from self-induced vomiting in BN is not linearly associated with the frequency or duration of vomiting (Milosevic and Dawson, 1996) . Similarly, amylase (Amy) levels are not significantly correlated with the severity of bulimic symptoms (Tylenda et al., 1991; Kronvall et al., 1992) . Thus, other salivary composition alterations may play a role. Salivary composition alterations are also known to significantly affect taste perception and oral sensation (Granot and Nagler, 2005) . Surprisingly, in spite of the fact that taste and salivary abnormalities may induce and exacerbate this eating disorder, only a handful of studies have examined these aspects, and even those studies did so on a limited, partial scale, never simultaneously examining all the variables examined in the current study.
The purpose of the current study was to systematically examine salivary composition and taste perception as well as to monitor related subjective complaints in a group of BN patients. Our a priori hypothesis was that changes in either taste perception or salivary composition might be associated with the active disease.
Materials and methods

Study design
Fifty-two consenting female individuals were recruited into the current study: 26 consecutive patients who were referred to the Eating Disorders Clinic, Psychiatric Division, Rambam Medical Center at Haifa, Israel, and diagnosed with BN according to the diagnostic and statistical manual of mental disorders-IV (DSM-IV) criteria (mean age: 2477 years) and another 26 age-matched, healthy controls who volunteered to participate in the study. The mean height of both groups was identical, 164 cm and the mean body weight of the two groups was not significantly different (BN group 61.3 kg and control group 58.5 kg). Thus the body mass index (BMI) of the BN group was slightly higher, yet not significantly different, than that of the control group (22.3 and 21.9, respectively) . Exclusion criteria for the study included a diagnosis of major depression or sarcoidosis, treatment with antidepressants such as selective serotonin reuptake inhibitors or tricyclic drugs, smoking or drinking. Practically, none of the consecutive BN patients had to be excluded from the study as none of them suffered from these diagnoses nor did they present these habits. All participants were then subjected to the following psychological questionnaires to indicate differences between cases and controls regarding either the presence or absence of BN and to evaluate to the level of disease activity: Beck Depression Inventory (BDI) (Beck et al., 1961) , brief symptom inventory (BSI) (Derogatis and Melisaratos, 1983) , impulsivity scale (IS) (Plutchik and Van Praag, 1989) , bulimic investigatory test Edinburgh (BITE) (Henderson and Freeman, 1987) and DSM symptomatology scale for anorexia and bulimia (DSM-SS) (Bachar et al., 1999) . In the last questionnaire, the patients and controls responded to a series of queries assessing eating disorders symptomatology, attitudes toward food, selfstructure and general psychiatric symptoms. The purpose of subjecting all participants to these questionnaires was to properly validate the presence or absence of BN. Following the questionnaires, all participants were also subjected to taste and salivary compositional analyses as described previously, and were monitored for an established subjective oral sensorial analysis (Nagler et al., 2002a; Granot and Nagler, 2005) . The sensorial analysis examined salivary/oral sensorial-related complaints as revealed in a structured questionnaire in which all subjects were asked to report xerostomia, the need for frequent mouth-rinsing, difficulties in masticating/swallowing or communicating and taste aberrations/burning sensation in the oral cavity (with no organic/local explanation), as described previously (Nagler et al., 1996) . These reported complaints related to their general state and was not specifically related to purge episodes. The entire examination procedure, which lasted approximately 2 h, was performed in the morning between 0080 and noontime by one expert only (for all the recruited participants who completed the entire analysis, with no exception). The salivary compositional analysis, performed at a later time, examined a wide spectrum of biochemical and antioxidant components. The biochemical analysis included various parameters, which reflect normal salivary functional composition in humans (Nagler et al., 2002b) : sodium (Na), chloride (Cl), potassium (K), calcium (Ca), inorganic phosphate (P), magnesium (Mg), total protein (TP), albumin (Alb), lactate dehydrogenase (LDH) and Amy. The salivary oxidative analysis included the main salivary antioxidant molecule -uric acid (UA) and enzymesperoxidase and superoxide dismutase (SOD) and the total antioxidant status (TAS).
Saliva collection
Saliva was collected using the widely accepted procedure as described previously (Nagler et al., 1996) , controlled to avoid drooling or swallowing. Whole saliva was collected under resting conditions in a quiet room between 0900 and noon at least 1 h after food intake. Subjects were asked to collect saliva in their mouths and to spit it into a wide-mouthed test tube for a period of 5 min. Saliva was then centrifuged and kept at 41C until analysis (within 1 week of collection, since previous studies have shown that saliva remains stable with respect to the parameters analyzed in such conditions).
Salivary compositional examination
Salivary biochemical analysis. The Na, Cl and K concentrations were measured by flame photometry, P concentration was measured spectophotometrically, and Ca and Mg concentrations were measured by atomic absorption as described previously (Baum et al., 1984; Ben-Aryeh et al., 1996) . TP was measured as described previously (Nagler et al., 2002a) , whereas Amy was measured by the Phadebas amylase test (Pharmacia Diagnostics, Uppsala, Sweden). Albumin was measured by the radial-immunodiffusion method (Mancini et al., 1965) , using an Oxford viewer for measuring the diameters of the precipitation rings (Mancini plates were purchased from Binding Side, Birmingham, UK). The diameter of the ring formed is quantitatively related to the concentration of various parameters analyzed. LDH was measured as described previously (Nagler et al., 2001) at 371C by an optimized standard method using pyruvate as the substrate with the Hitachi 911 automated clinical chemistry analyzer using reagents purchased from Roche Diagnostics (Mannheim, Germany). The assay coefficient of variation (CV) was 2.1%. Amy was measured at 371C using 4,6-ethylidene (G 7 )-p-nitrophenyl (G 1 )-a,D-maltoheptaoside as substrate as described previously (Rauscher et al., 1985) ; the assay CV was 3.4%.
Salivary oxidative analysis UA. UA concentration was measured both in the saliva of the patients using a kit supplied by Sentinel CH (Milan, Italy), as described previously (Nagler et al., 2002a) . UA is transformed by uricase into allantoin and hydrogen peroxide which, under the catalytic influence of peroxidase, oxidizes the chromogen (4-aminophenazone/N-ethyl-methylanilin propan-sulfonate sodic) to form a red compound whose intensity of color is proportional to the amount of UA present in the sample and is read at a wavelength of 546 nm.
Peroxidase activity. Peroxidase activity was measured both in the patients' saliva according to the 5-thio-2-nitrobenzoic acid (NBS) assay, as described previously (Reznick et al., 2003) . Briefly, the calorimetric change induced by the reaction between the enzyme and the substrate, dithiobis 2-nitrobensoic acid in the presence of mercapto-ethanol, was read at a wavelength of 412 nm for 20 s.
SOD activity. The total salivary activity of the SOD enzyme (Cu/Zn-and Mn-SOD) was measured using the xanthine oxidase/tetrazolium salt (XTT) method. The method is a modification of the nitroblue tetrazolium (NBT) assay, in which XTT is reduced by superoxide anion (SO) generated by xanthine oxidase. Formazan is read at 470 nm. The SOD enzyme inhibits this reaction by scavenging SO. One unit of the enzyme is defined as the amount needed for a 50% inhibition of the absorption (Nagler et al., 2002b) .
TAS. TAS was assessed in the saliva samples, as described previously (Nagler et al., 2002a) . Briefly, this assay is based on a commercial kit supplied by Randox Laboratories Ltd, Crumlin, Co. Antrim, UK in which metmyoglobin in the presence of iron is turned into ferrylmyoglobin. Incubation of the latter with the Randox reagent 2,2 0 -azinobis (3-ethylbenzothiazoline-6-sulfonate) (ABTS) results in the formation of a radical-colored blue-green, which can be detected at 600 nm.
Taste analysis
The three-stimuli staircase, forced-choice drop technique using NaCl, sucrose, citric acid and urea (all in 1, 0.5 and 0.025% solutions for the high, intermediate and low concentrations) as stimuli for salty, sweet, sour and bitter tastes, respectively, measured taste acuity. The cumulative scores of taste disturbances were calculated according to the threshold concentrations of taste stimulant detected by the subject. Thus, a lack of detection of the lower, intermediate or highest concentrations of each specific taste was scored as 1, 2 or 3, respectively, and was considered a 'taste disturbance.' Thus, when the subject failed to detect the lowest concentration of the taste examined, it was considered as only mild subjective taste disturbance. However, if the subject failed to detect the moderate or the highest concentrations, the specific taste disturbance was considered moderate or profound, respectively. A similar three-concentration taste analysis was performed for all four tastes examined. Results obtained were accumulated to form the total score for the cumulative severity of taste disturbance for each patient. The various concentrations of the chemicals used in the taste analyses were based on previously published assays (Markley et al., 1983; Henkin, 1987) and calibration tools used according to assay guidelines.
Statistical analysis
For categorical variables, frequencies, percentages and distribution were calculated. Distribution for categorical variables was compared by w 2 test (large sample) and the Fisher-Irwin exact test (small sample). Owing to the large inherent variability of parameters in saliva, medians values, whereas for disease parameters mean7s.e.) were calculated. The medians of saliva parameters between pairs of subgroups (patients and controls) were compared by a two-sample Wilcoxon rank-sum test (non-parametric). The results of disease parameters between pairs of subgroups (patients and controls) were compared by a two-sample t-test (parametric). The correlations between parameters were analyzed with the Pearson's correlation.
Results
BN characteristics
Eighty-one percent of the BN patients reported uncontrolled binge eating episodes ranging from several per day to at least twice per week, whereas the remaining 19% reported a binge episode prevalence of at least once a week. All BN patients used vomiting at least once per week as a compensatory strategy. Four (15%) reported vomiting episodes once per week, nine (35%) vomiting episodes twice per week, 10 (39%) vomiting episodes once per day and three (11%) vomiting episodes multiple times per day. Thus our sample of BN patients was a rather wide-spectrum BN. No significant differences were noted among the subgroups of BN patients according to their various levels of binge/purge behavior, whereas there was a significant difference between the healthy controls and the BN patients known for binge/purge behaviors. In any case, regardless of the prevalence of the binge episodes, these were accompanied by compensating behavior which included not only the self-induced vomiting but also the use of drugs, such as diuretics, laxatives and amphetamines, excessive physical training, fasting, and so on, as previously reported for BN patients (Beck et al., 1961; Derogatis and Melisaratos, 1983; Henderson and Freeman, 1987; Plutchik and Van Praag, 1989; Bachar et al., 1999) . Furthermore, as demonstrated by Table 1 , the questionnaires relating to BITE, BDI, BSI and IS revealed highly significant differences between the BN and control groups concerning the various BN diagnostic symptoms (P ¼ 0.0001, indicative of their various disturbed general health and nutritional habits, psychological and psychiatric characteristics. The overall mean BITE-total score for the BN patients was 61.375.8, whereas for controls it was 37.875.6 (P ¼ 0.0001); the overall mean BITE-symptoms score for the BN patients was 51.474.0, whereas for controls it was 36.474.9 (P ¼ 0.0001); the overall mean BITE-severity score for the BN patients was 9.973.4, whereas for controls it was 1.471.3 (P ¼ 0.0001); the overall mean BDI grade for the BN patients was 9.973.4, whereas for controls it was 1.471.3 (P ¼ 0.0001); the overall mean BSI grade for the BN patients was 103.0742.2, whereas for controls it was 21.0718.8 (P ¼ 0.0001); the overall mean IS grade for the BN patients was 31.074.9, whereas for controls it was 24.073.8 (P ¼ 0.0001).
Salivary biochemical and oxidative analysis
No significant difference was noted between the salivary flow rate of the patients and controls. The median salivary pH of the BN patients was 6.7, significantly lower than that of the controls, which was 7.0 (Po0.05). The Ca, P and Mg concentrations in the BN group were 1.6, 18.4 and 0.7 mg/dl, respectively. Their median concentrations in the control group were lower by 16 (Po0.52), 13 (Po0.18) and 29% (Po0.002), respectively. The median Na, K and Cl concentrations of the BN patients were 20, 23 and 25 mmol/l, respectively. In the control group, the Na concentration was similar, whereas the median concentrations of the K and Cl were lower by 7 (Po0.17) and by 6% (Po0.04), respectively ( Table 1 ). The median concentrations of TP and albumin in the BN group were 70 and 55 mg/dl, respectively, higher by 22 (Po0.065) and 13% (Po0.52) than those of the control group. In contrast, the median LDH activity value of the BN group was 6 IU/l, significantly lower than that of the control group (by 72%, Po0.05), and the median Amy activity value of the BN group was 609 IU/l, lower by 20% than that of the controls (Po0.62) (Figure 1 ). The median concentration of the UA was 2.35 mg/dl, significantly higher than that of the control group (by 67%, Po0.002). Similarly, the median concentration of the TAS was 0.43 mmol/l, higher than that of the control group by 26% (Po0.09) (Figure 2 ).
Taste analysis
Although 73% of the BN patients had difficulty in properly detecting salt, only 27% of the controls had a similar Salivary changes in bulimia patients T Blazer et al problem and the difference between the two groups was highly significant (0o0.003). No statistically significant differences were found for the other three tastes analyzed (sweet, sour and bitter); yet, the overall accumulative taste disturbance level of the BN patients was significantly higher than that of the controls (Table 2 ). No significant difference was found between the patients reporting compensative vomiting and others in respect to taste disturbances.
Subjective complaints
Complaints of xerostomia were far more prevalent among the BN patients than in the control group and the difference between the groups was highly significant (Po0.003) ( Table 3) . Sixty-two percent of the controls did not complaint of xerostomia, whereas 77% of the BN patients did. Furthermore, although all those in the control group who complained of xerostomia had only mild complaints, not less than 31% of the BN patients complained of moderate to severe xerostomia, whereas the other 46% of the BN patients complained of mild xerostomia (Table 3) . Similarly, 47% of the BN patients complained of taste disturbances and/or burning sensorial disturbance in the oral cavity, whereas only 19% of the controls had similar complaints and the difference here, too, was significant (Po0.016) (Table 3) . Interestingly, there were no statistically significant differences between the BN patients and the healthy controls regarding the prevalence of the need for mouth rinsing or regarding difficulties in mastication, swallowing or communication.
Discussion
For the first time both subjective and objective examinations have shown that an overall disturbed salivary and taste profile is found in BN patients (the salivary compositional and taste examinations were accompanied by complaints of xerostomia and taste aberration or oral burning sensation typical of this illness. Such an altered salivary composition and taste/sensorial disturbance may be the initiating trigger for BN or vice versa, it may be its consequence. In any case, even if it is not the initiator of BN, it can certainly aggravate the situation and push patients into a vicious circle of eating disturbance, that is once started, altered oral well-being induces either a reduction in eating (accompanied by excessive, uncontrolled binge eating episodes) or may by itself induce the eagerness to eat. The subjective complaint of xerostomia may result merely from altered salivary composition, as reported previously (Granot and Nagler, 2005) . The sensation of dry mouth in BN patients has already been reported by Paszynska et al. (2006) . Xerostomia may result from an objective reduction in salivary flow rate in BN patients, as it was also reported previously (Paszynska et al., 2006) . However, it is well known (Nagler et al., 2002a; Granot and Nagler, 2005) that subjective feeling of xerostomia may result from salivary compositional changes, which are not accompanied by an actual decrease of flow rate, as we currently report. The fact that not all the observed altered salivary concentrations were statistically significant may result merely from the well-known inherent physiological variability of salivary composition (Hardt et al., 2005) . Owing to this well-known large variability, there was no point in trying to correlate salivary changes with the obtained BN-related clinical data. However, in future studies such a correlation analysis should be conducted with much higher number of individuals in both the BN and control groups. Regardless of the reason for these observed multiple compositional alterations, the patient's saliva may be less able to fulfill some of its normal biological roles as all the above components have physiological functions, and when altered, the functions may be compromised. In contrast, some of the functions may be supported by the increase in the salivary concentrations. For example, electrolites such as Cl, Mg, and so on are important for the re-mineralization power of saliva (required for its ability to combat caries) and for maintaining its buffering capacity. Interestingly, in contrast to the significantly increased UA, which is the most important salivary antioxidant molecule (Nagler et al., 2002b) , there was no significant difference in the activity of the most important salivary antioxidant enzymes examined, that is peroxidase and SOD. Hence, this differentiated reduction of the various salivary components may result from a differentiated effect of the disease on various aspects of the salivary functioning, which in turn may stem from an autonomic nerve disorder, as suggested by Riad et al. (1991) . Regardless of the specific significance of each salivary compositional alteration, our results gain credit from other studies that found similar salivary results, such as statistically not significantly altered salivary K, P and albumin in BN patients, as well as decreased pH (Riad et al., 1991; Tylenda et al., 1991) . Similar to the complaint of xerostomia, the subjective complaint of taste disturbance may also result merely from altered salivary composition, as we have previously reported (Granot and Nagler, 2005) . However, taste perception in BN may be affected by purging, since vomit is directed toward the oral mucosa where the taste receptors are located, and these may be damaged by the acids in vomit (Rodin et al., 1990) . In this regard, the fact that no significant difference was found between the patients reporting compensative vomiting and others in respect to taste disturbances may result form the fact that we studied a group of patients which was too small and in any case this should be reexamined in a substantially larger group. Another explanation for the relationship between BN and taste aberrations was suggested recently by Avena et al. (2006) , who related taste in BN to an altered central mechanism based on abnormal levels of the neurotransmitters dopamine and acetylcholine.
Regardless of the specific mechanism responsible for the disturbed salivary and taste profiles in BN patients, the data presented may serve the clinician for diagnostic purposes on one hand, and maybe for further understanding of the pathogenesis of the disease on the other. This as salivary/ taste disturbances may trigger eating disorder and/or aggravate it, and the fact that we currently did not demonstrate a significant correlation between these and the patient's clinical manifestation may result merely from the relatively small group of patients analyzed and its heterogenicity. Hence, a further study is warranted in larger cohorts of BN patients and also to try and determine whether these disturbed salivary and taste profiles in BN patients are normalized with recovery. In case these are found to be normalized, administration of therapeutic agents, including antioxidants, anti-inflammatory drugs and saliva substitutes, to the oral cavity (and perhaps even systemically) of BN patients, should be considered. 
